Extended high efficacy of the combination sulphadoxine-pyrimethamine with artesunate in children with uncomplicated falciparum malaria on the Benin coast, West Africa

Table 4 Clinical failures (CF) by day 42, 63 and 90 post-treatment, by clinical outcome at day 28 and treatment group

Outcome at D28°	Treatment group (N)	CF					Total CF D29-90
Outcome at D28°	Treatment group (N)		D7-28	D29-42	D43-63	D64-90	Total CF D29-90
ACPR (n = 123)	SP-AS	R	0	0	0	0	0
	68	N	0	0	2	5	7
	CQ	R	0	1	0	0	1
	18	N	0	1	0	0	1
	SP 37	R	0	1	0	2	3
	37	N	0	0	0	1	1
LPF new infection (n = 7)	SP-AS	R	0	0	0	0	0
	4	N	0	1	0	0	1
	CQ	R	0	0	0	0	0
	2	N	0	0	0	0	0
	SP	R	0	0	0	0	0
	1	N	0	0	0	1	1
LPF recrudescence (n = 38)	SP-AS	R	0	0	1	0	1
	3	N	0	0	0	0	0
	CQ	R	3	0	0	0	3
	25	N	0	0	1	2	3
	SP	R	4	0	0	0	4
	10	N	0	0	0	0	0

°ACPR: Adequate Clinical and Parasitological Response;
LPF: Late Parasitological Failure; R = recrudescence; N = new infection; D = day).